Investor Portal

Tenaya Therapeutics is a clinical stage biotechnology company committed to a bold mission: to discover, develop and deliver curative therapies that address the underlying drivers of heart disease. Tenaya is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. Tenaya was founded by leading cardiovascular scientists from Gladstone Institutes and the University of Texas Southwestern Medical Center.